Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DiaceuticsDIUXF 90 Operating Cash Flow per Share is $0.02 as of Dec. 2025. GuruFocus rates DIUXF with a GF Score™ of 90/100 and a GF Value™ of $2.51. The stock has 1 warning sign investors should review. Among 521 Healthcare Providers & Services companies, Diaceutics ranks worse than 94.82% on this metric.
Diaceutics's operating cash flow per share for the
six
months ended in Dec. 2025 was $0.01.
Diaceutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Diaceutics was 75.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -38.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Diaceutics's Operating Cash Flow per Share or its related term are showing as below:
DIUXF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -48.5 Med: -16.75 Max: 74.7
Current: -38.1
During the past 10 years, Diaceutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 74.70% per year. The lowest was -48.50% per year. And the median was -16.75% per year.
DIUXF's 3-Year OCF Growth Rate is ranked worse than 94.82% of 521
companies
in the Healthcare Providers & Services industry
Industry Median: 9.4
vs DIUXF: -38.10
Diaceutics Operating Cash Flow per Share Related Terms
Diaceutics Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Diaceutics's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DIUXF vs VEEV, BTSG, TEM: Operating Cash Flow per Share Comparison
For the Health Information Services subindustry, Diaceutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diaceutics Price-to-Operating-Cash-Flow vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diaceutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Diaceutics's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.02 mean?
Diaceutics (DIUXF) has a Operating Cash Flow per Share of $0.02 as of Dec. 2025. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Diaceutics and its competitors. According to the industry distribution chart, Diaceutics ranks #494 out of 521 companies in the Healthcare Providers & Services industry, placing it in the top 94.8%.
Is Diaceutics' Operating Cash Flow per Share too high?
Diaceutics' current Operating Cash Flow per Share is $0.02. The Healthcare Providers & Services industry median Operating Cash Flow per Share is 9.40. Diaceutics' value of $0.02 is 99.8% below this industry median. Based on the distribution chart, Diaceutics ranks #494 out of 521 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Diaceutics has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Operating Cash Flow per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diaceutics ranks #494 out of 521 companies for Operating Cash Flow per Share. This places Diaceutics in the lower half of its industry. The industry median Operating Cash Flow per Share is 9.40. Diaceutics' value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Healthcare Providers & Services company?
The median Operating Cash Flow per Share among Healthcare Providers & Services companies is 9.40, based on 521 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diaceutics's current Operating Cash Flow per Share of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Diaceutics and its competitors. For the Healthcare Providers & Services industry, the median Operating Cash Flow per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diaceutics's current Operating Cash Flow per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Diaceutics (DIUXF) has a current Operating Cash Flow per Share of $0.02. The stock's GF Value™ is $2.51, compared to a current price of $2.00 — trading 20.3% below its estimated fair value. The current Operating Cash Flow per Share is $0.02 and 99.8% below the Healthcare Providers & Services industry median of 9.40. Diaceutics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Diaceutics (DIUXF), the current Operating Cash Flow per Share is $0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diaceutics (DIUXF) Overvalued in 2026?
Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued.
The current stock price of $2.00 is trading 20.3% below its estimated GF Value™ of $2.51.
Key valuation signals for DIUXF:
Operating Cash Flow per Share: $0.02
GF Value™: $2.51 vs. price of $2.00 (20.3% below fair value)
Industry Position: 99.8% below the Healthcare Providers & Services median (#494 of 521)
No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
90GF Score
Get the complete analysis for DIUXF
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DIUXF has been successfully added to your 
